Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPER Project: Digital Vital Sign Monitoring for Sleep in Cancer Patients
NCT05456360Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: EuroQol Group EQ-5D at 1 year. Started Mar 2023; status: terminated.
Beyond the preview
Go deeper on NCT05456360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05456360.